Here's Why Investors Must Hold NSP Stock in Their Portfolios for Now
Insperity stock is up 51% in 3 months; 2026 earnings are seen to grow 106.8% as HRScale and margin recovery gain traction amid macro risks.
Insperity Q1 Earnings Beat Estimates on Margin Recovery
NSP beats Q1 EPS and revenue estimates as margin recovery takes hold despite a dip in average paid worksite employees.
Insperity, Inc. (NSP) Q1 2026 Earnings Call Transcript
Insperity, Inc. (NSP) Q1 2026 Earnings Call Transcript
Insperity, Inc. (NSP) Q1 Earnings and Revenues Top Estimates
Insperity, Inc. (NSP) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.24 per share. This compares to earnings of $1.57 per share a year ago.
Why Is Insperity (NSP) Down 33.7% Since Last Earnings Report?
Insperity (NSP) reported earnings 30 days ago. What's next for the stock?
Insperity Stock Price Decreases 18% After Reporting Loss in Q4
NSP shares sink after the fourth-quarter 2025 loss, a revenue miss and a weak 2026 EPS outlook overshadow modest WSEE growth and a higher cash balance.
Insperity, Inc. (NSP) Q4 2025 Earnings Call Transcript
Insperity, Inc. (NSP) Q4 2025 Earnings Call Transcript
Insperity, Inc. (NSP) Reports Q4 Loss, Lags Revenue Estimates
Insperity, Inc. (NSP) came out with a quarterly loss of $0.6 per share versus the Zacks Consensus Estimate of a loss of $0.49. This compares to earnings of $0.05 per share a year ago.
Insperity: A High-Quality PEO Trading At A Cyclical Low
Insperity trades at a depressed valuation after a 70% drawdown, despite having a net-cash balance sheet and historically successful business model. NSP's partnership with Workday aims to modernize its tech stack and improve client retention. Short-term margin compression stems from elevated healthcare costs and HRScale integration expenses, but these headwinds are expected to subside through 2026.
Insperity: A Value Opportunity With 2026 Recovery Catalysts (Rating Upgrade)
Insperity, Inc. has managed to maintain stable revenues despite more challenging macroeconomic trends. Current earnings have been pressured by an unexpected surge in healthcare costs. Insperity is set to start a margin recovery starting in 2026. The market clearly undervalues Insperity's rebound potential. I estimate 74% upside to $67.0.
Why Is Insperity (NSP) Down 6.5% Since Last Earnings Report?
Insperity (NSP) reported earnings 30 days ago. What's next for the stock?
Insperity Stock Down 55% From Highs as Hedge Fund Buys $13 Million Stake — Is It A Turnaround Bet?
Connecticut-based Stadium Capital Management added 263,715 shares of Insperity worth $13 million in the third quarter. The transaction represented a new position for Stadium Capital, which reported holding no shares of Insperity in the previous period.
